News & Events

By immersing ourselves in events and initiative, our expert teams are designed to keep you informed about the latest industry developments. Our goal is to provide essential support and tools for the success of your own groundbreaking projects.
Curapath & Certest Join Forces to Offer Next-Generation Lipid Nanoparticles (LNP) Formulations with Proprietary Excipients

VALENCIA & ZARAGOZA, SPAIN, 07 OCT 2024. Curapath, a leading innovator in the manufacturing of novel lipid and polymer excipients, nanoparticle formulations and innovative polymer conjugates,...

Curapath Strengthens Partnership in Breakthrough Genetic Medicine with Multiyear Development and Manufacturing Agreement

BOSTON and VALENCIA, Feb. 14, 2024 – Curapath, a leader in the development and custom manufacturing of polymer- and lipid-based delivery systems for advanced therapies, has...

Curapath Appoints Philippe Clavel as Chief Executive Officer

Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer....

Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

Valencia, Spain and Boston, MA, January 26, 2023 – Curapath, a leader in the design, development, andcustom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems...

Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine

Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine Valencia, Spain and Boston, MA, November 16, 2022 – Curapath, a...

Innovation and Technology highlights at Curapath
Proyecto cofinanciado por los Fondos FEDER, dentro del Programa Operativo FEDER de la Comunidad Valenciana 2021-2027

Desarrollo de nuevas plataformas de lípidos y su optimización en el uso de nanopartículas lipídicas para el transporte de material genético

PROGRAMA: AYUDAS PARA PROYECTOS DE I+D PYME PIDI-CV Nº Expediente: IMIDTA/2023/73

Proyecto subvencionado por el CDTI y apoyado por el Ministerio de Ciencia e Innovación

Investigación de nueva vacuna para enfermedad respiratoria humana

(VSRVAC)

PROGRAMA: Programa Misiones Empresas

Nº Expediente: EXP 00146282 / MIG-20211034

POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. ha llevado a cabo en el año 2024 un proyecto de inversión importante en sus instalaciones con un importe subvencionado de 110.427,00 € y concedido por la Conselleria de Innovación, Industria, Comercio y Turismo a través del expediente INPYME/2024/947 dentro de la convocatoria de ayudas INPYME 2024 (Ayudas para apoyar las inversiones productivas realizadas por las PYMES de diversos sectores industriales de la Comunitat Valenciana para el ejercicio 2024 (INPYME). Industria)